Cargando…

Influence of prothrombin complex concentrates on plasma coagulation in critically ill patients

Objective: To evaluate thrombogenicity of prothrombin complex concentrates (PCCs) in critically ill patients.¶Design: Prospective clinical study.¶Setting: Medical intensive care unit at a university hospital.¶Patients: 16 consecutive patients suffering from acquired deficiencies of coagulation facto...

Descripción completa

Detalles Bibliográficos
Autores principales:	Staudinger, T., Frass, M., Rintelen, C., Quehenberger, P., Wagner, O., Stoiser, B., Locker, G. J., Laczika, K., Knapp, S., Watzke, H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 1999
Materias:	Original
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094948/ https://www.ncbi.nlm.nih.gov/pubmed/10551966 http://dx.doi.org/10.1007/s001340051019

Ejemplares similares

Outcome and prognostic factors in critically ill immunocompromised patients admitted to the ICU
por: Schellongowski, P, et al.
Publicado: (2004)

Physiological effects of lateral steep positioning in critically ill patients suffering from acute respiratory distress syndrome (ARDS)
por: Staudinger, T, et al.
Publicado: (2004)

Theoretical Modeling of Coagulation Management With Therapeutic Plasma or Prothrombin Complex Concentrate
por: Schöchl, Herbert, et al.
Publicado: (2017)

Role of prothrombin complex concentrate in perioperative coagulation therapy
por: Tanaka, Kenichi A, et al.
Publicado: (2014)

Treatment of adults with sepsis-induced coagulopathy and purpura fulminans with a plasma-derived protein C concentrate (Ceprotin)(®)
por: Schellongowski, P, et al.
Publicado: (2003)

Continuous infusion versus intermittent administration of meropenem in critically ill patients: a pilot study
por: Thalhammer, F, et al.
Publicado: (1999)

Acquired deficiency of prothrombin complex coagulation factors in major bleeding is a therapeutic indication of 4‐factor prothrombin complex concentrates
por: Wiedermann, Christian J.
Publicado: (2020)

Prothrombin Complex Concentrates to Treat Coagulation Disturbances: An Overview With a Focus on Use in Infants and Children
por: Munlemvo, Dolly M., et al.
Publicado: (2022)

Factors contributing to poor outcome in patients on warfarin receiving 4-factor prothrombin complex concentrate in critically ill
por: Mishra, Ajay Kumar, et al.
Publicado: (2021)

Treatment of the coagulation deficit during extracorporeal circulation in a porcine model by a prothrombin complex concentrate
por: Kaspereit, F, et al.
Publicado: (2010)

PROTHROMBIN COMPLEX CONCENTRATE  IN EMERGENCY DEPARTMENT
por: Nesek Adam, Višnja, et al.
Publicado: (2022)

Short-term effects of combining upright and prone positions in patients with ARDS: a prospective randomized study
por: Robak, Oliver, et al.
Publicado: (2011)

Coagulation Factor Plasma Levels Following Administration of a 4-Factor Prothrombin Complex Concentrate for Rapid Vitamin K Antagonist Reversal in Japanese Patients
por: Yasaka, Masahiro, et al.
Publicado: (2018)

Prothrombin complex concentrates in warfarin anticoagulation reversal
por: Costa-Lima, Carolina, et al.
Publicado: (2012)

Prothrombin Complex Concentrates Only After Thromboelastography
por: Muggleton, Ellis, et al.
Publicado: (2019)

Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM(®))-guided administration of fibrinogen concentrate and prothrombin complex concentrate
por: Schöchl, Herbert, et al.
Publicado: (2010)

Coagulation in chronic liver disease and the use of prothrombin complex concentrate for an emergent procedure: a case report and review of literature
por: Laubham, Matthew, et al.
Publicado: (2018)

Prothrombin complex concentrates for DOAC‐associated bleeding, global coagulation assays, and assessments of clinical hemostasis: How to gauge the impact?
por: Shaw, Joseph R., et al.
Publicado: (2020)

Four-factor prothrombin complex concentrate (Beriplex® P/N) is superior to three-factor prothrombin complex concentrate for reversal of coumarin anticoagulation
por: Herzog, E, et al.
Publicado: (2015)

Reversal of oral anticoagulation with prothrombin complex concentrate (Octaplex)
por: Riess, H, et al.
Publicado: (2007)

Role of prothrombin complex concentrate in the severe trauma patient
por: Egea-Guerrero, Juan José, et al.
Publicado: (2022)

Thromboembolism after treatment with 4-factor prothrombin complex concentrate or plasma for warfarin-related bleeding
por: Go, Alan S., et al.
Publicado: (2022)

Critically ill patients with cancer: chances and limitations of intensive care medicine—a narrative review
por: Schellongowski, Peter, et al.
Publicado: (2016)

Clinical review: Prothrombin complex concentrates - evaluation of safety and thrombogenicity
por: Sørensen, Benny, et al.
Publicado: (2011)

The role of prothrombin complex concentrates in reversal of target specific anticoagulants
por: Babilonia, Katrina, et al.
Publicado: (2014)

Using of prothrombin complex concentrate in patients with trauma-induced coagulopathy
por: Tarabrin, O, et al.
Publicado: (2015)

Comparison of prothrombin complex concentrate and fresh frozen plasma on thrombin generation and hemorrhage in experimental dilutional coagulopathy
por: Dickneite, G, et al.
Publicado: (2008)

Administration of a standardized plasma-protein solution (Biseko(®)) in high-risk patients with systemic inflammatory response syndrome: influence on cytokine levels and survival
por: Meyer, B, et al.
Publicado: (2008)

Prothrombin complex concentrate vs fresh frozen plasma for reversal of dilutional coagulopathy in a porcine trauma model
por: Dickneite, G., et al.
Publicado: (2009)

Comparing prothrombin complex concentrate and fresh frozen plasma with blood viscosity characteristics in patients with trauma-induced coagulopathy
por: Tarabrin, O, et al.
Publicado: (2015)

Prothrombin, alone or in complex concentrates or plasma, reduces bleeding in a mouse model of blood exchange-induced coagulopathy
por: Eltringham-Smith, Louise J., et al.
Publicado: (2019)

STUDIES ON BLOOD COAGULATION : I. THE RÔLE OF PROTHROMBIN AND OF PLATELETS IN THE FORMATION OF THROMBIN
por: Eagle, Harry
Publicado: (1935)

Correction: Clinical review: Prothrombin complex concentrates - evaluation of safety and thrombogenicity
por: Sørensen, Benny, et al.
Publicado: (2011)

Thrombin Generation Capacity of Prothrombin Complex Concentrate in an In Vitro Dilutional Model
por: Grottke, Oliver, et al.
Publicado: (2013)

Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation
por: Grottke, Oliver, et al.
Publicado: (2016)

PROTHROMBIN COMPLEX CONCENTRATE USE IN BELFAST HEALTH AND SOCIAL CARE TRUST
por: Corrigan, C, et al.
Publicado: (2021)

Prothrombin time is predictive of low plasma prothrombin concentration and clinical outcome in patients with trauma hemorrhage: analyses of prospective observational cohort studies
por: Balendran, Clare A., et al.
Publicado: (2017)

Coagulation abnormalities in critically ill patients
por: Levi, Marcel, et al.
Publicado: (2006)

The effect of vitamin K on prothrombin time in critically ill patients: an observational registry study
por: Dahlberg, Sofia, et al.
Publicado: (2021)

PLASMA PROTHROMBIN: EFFECT OF PARTIAL HEPATECTOMY
por: Warner, E. D.
Publicado: (1938)

Cannot write session to /tmp/vufind_sessions/sess_ocmrdrhmcqns6hmo8842rn2ck6